Corbion Purac Takes Lactic Acid Business of Malladi Specialties

Netherlands-based Corbion Purac has signed an agreement with Malladi Specialties Limited (MSL) of India covering marketing and supply of lactic acid and derivatives. Part of the Malladi group, one of India's leading pharmaceutical companies, MSL will retain the production assets and toll manufacture for Corbion.

Financial terms of the deal were not disclosed.

The Indian producer supplies regional pharmaceutical, home & personal care, chemical and food industries with products including calcium lactate, sodium lactate and buffered lactic acid. The partnership will give Corbion a local production base while maintaining control over quality of supply, the Dutch company said.

Noting that Corbion “has been an established name and superior service provider in the food and pharmaceutical industry with lactic acid and its derivatives for 80 years,” Frank Goovaerts, regional vice president at Corbion Purac Asia Pacific, said that with MSL’s strong local customer base and distribution network, his company will be able to expand its distribution network and customer service in India.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.